Research
Dr Matthew Anson studied Medicine at St George’s, University of London, graduating with distinction with an additional six academic prizes, and intercalated in Clinical and Molecular Endocrinology at King’s College London, where he was awarded the prize for best performing student, presenting his research internationally. Following graduation, Dr Anson undertook a Diabetes themed Academic Foundation Programme in Liverpool, during which he published multiple peer-reviewed papers, including in Diabetologia and Diabetes, Obesity and Metabolism. He subsequently completed an MPhil investigating complications of type 2 diabetes. Dr Anson then undertook a post as an NIHR-funded Academic Clinical Fellow in Diabetes and Endocrinology, and passed his membership exams for the Royal College of Physicians, prior to commencing a PhD fellowship jointly funded by the Novo Nordisk UK Research Foundation and Breakthrough T1D, focusing on early worsening of diabetic retinopathy in individuals with type 1 diabetes newly initiating on hybrid closed loop therapies. His research interests span pharmacotherapy in diabetes, cardiovascular and microvascular complications, the use of technology and data-driven approaches to improve care, early intervention strategies in both type 1 and type 2 diabetes, and the development and application of emerging novel immunotherapies in type 1 diabetes.
Research grants
INSIGHT 1
LIVERPOOL UNIVERSITY HOSPITALS CHARITY (UK)
March 2025 - July 2029